References
- Prentice C RM, Edgar W, McNicol GP. Characterization of fibrin degeneration products in patients on ancrod therapy. Br J Haematol 1974; 27: 77–87
- Brendenkamp J K, Shelton C. Sudden hearing loss. Postgrad Med 1987; 86: 125–32
- Ohara I, Sasaki H. The effect of batroxobin on peripheral circulatory disturbance. Igaku to Yakugaku 1983; 9: 1643–55
- Kubo T, Okumura S, Asai HT. Effects of defibrinogenation therapy on idiopathic hearing loss. Otol Fukuoka 1985; 31: 1231–6
- Kohler W, Martin M, Krupe M. Therapeutische Effekte auf den Stoffweehsel durch Verminderung der Blutviscositat (Defibrase). Verh Dtsch Ges Inn Med 1973; 79: 1400
- Nasu Y, Shingu H, Kimura I. Defibrinogating therapy of peripheral circulatory disturbance in vibration syndrome. Jap J Traumatol Occup Med 1985; 33: 591–604
- Meissner J A, Karpowicz M, Konopka L. Changes in the muscle rest blood flow associated with therapeutic defibrinogenation. Eur Surg Res 1977; 9-S1: 111–7
- Kawakami M, Makimoto K, Fukuse S, Takahashi H. Effects of a depressor on cochlear microcirculation. Acta Otolaryngol (Stockh) 1991; 111: 743–9
- Kawakami M, Makimoto K, Fukuse S, Takahashi H. Autoregulation of cochlear blood flow. A comparison of cerebral blood flow wilth muscular blood flow. Eur Arch Otorhinolaryngol 1991; 248: 471–4
- Kawakami M, Makimoto K, Noi O, Takahashi H. Relationship between cochlear blood flow and perilymphatic oxygen tension. Eur Arch Otorhinolaryngol 1991; 248: 465–70
- Nuttall A L, Hultcrantz E, Larsen H C, Angelborg C. Cochlear blood flow increases after systemic hemodilution: comparison of simultaneous laser Doppler flowmetry and radioactive microsphere measurements. Hear Res 1988; 34: 215–24
- Umehara N, Sha Y, Hoki N, Tomonaga G, Kajiya F. Analysis of pressure-flow relation in femoral artery by vascular waterfall model and an application to drug evaluation. Shinzo 1983; 16: 433–40
- Sugawara M, Akiyama K, Asano M. Effects of batroxobin on microcirculation. J Jap Biorheol Soc 1982; 5: 159–62
- Ishimaru S, Konishi M, Hirayama T. Application of the defibrinogenation therapy for surgery. Acta Haematol Jpn 1981; 44: 732–8
- Latallo Z S, Lopaciuk S. New approach to thrombolytic therapy. Thromb Diathes Haemost 1973; 253–5, Suppl 56
- Ohba M, Aoyama M, Sha Y. General pharmacological studies on batroxobin (DF-521) a defibrinogating agent. Igaku to Yakugaku 1985; 14: 1023–45
- Shiraishi T, Kubo T, Matsunaga T. Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Acta Otolaryngol (Stockh) 1991; 111: 867–71